EFFECT OF ADENOSINE ON MITOGENESIS OF ADA-DEFICIENT LYMPHOCYTES

被引：14
|
作者：
UBERTI, J [1 ]
LIGHTBODY, JJ [1 ]
WOLF, JW [1 ]
ANDERSON, JA [1 ]
REID, RH [1 ]
JOHNSON, RM [1 ]
机构：
[1] HENRY FORD HOSP, DEPT MED, DIV ALLERGY & CLIN IMMUNOL, DETROIT, MI 48201 USA
来源：
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1978年 / 10卷 / 04期
关键词：
D O I：
10.1016/0090-1229(78)90157-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：446 / 458
页数：13
相关论文
共 50 条
  • [41] ADENOSINE DEAMINASE (ADA) ACTIVITY IN TISSUES OF ADA DEFICIENT-COMBINED IMMUNODEFICIENT (CID) PATIENTS
    POLLARA, B
    PICKERING, RJ
    MEUWISSEN, HJ
    PEDIATRIC RESEARCH, 1975, 9 (04) : 334 - 334
  • [42] Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreduction
    Carbonaro, Denise A.
    Jin, Xiangyang
    Wang, Xingchao
    Yu, Xiao-Jin
    Rozengurt, Nora
    Kaufman, Michael L.
    Wang, Xiaoyan
    Gjertson, David
    Zhou, Yang
    Blackburn, Michael R.
    Kohn, Donald B.
    BLOOD, 2012, 120 (18) : 3677 - 3687
  • [43] Dosing and Re-Administration of Lentiviral Vector for In Vivo Gene Therapy in Rhesus Monkeys and ADA-Deficient Mice
    Carbonaro-Sarracino, Denise A.
    Tarantal, Alice F.
    Lee, C. Chang, I
    Kaufman, Michael L.
    Wandro, Stephen
    Jin, Xiangyang
    Martinez, Michele
    Clark, Danielle N.
    Chun, Krista
    Koziol, Colin
    Hardee, Cinnamon L.
    Wang, Xiaoyan
    Kohn, Donald B.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 16 : 78 - 93
  • [44] ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency
    Sauer, Aisha V.
    Mrak, Emanuela
    Hernandez, Raisa Jofra
    Zacchi, Elena
    Cavani, Francesco
    Casiraghi, Miriam
    Grunebaum, Eyal
    Roifman, Chaim M.
    Cervi, Maria C.
    Ambrosi, Alessandro
    Carlucci, Filippo
    Roncarolo, Maria Grazia
    Villa, Anna
    Rubinacci, Alessandro
    Aiuti, Alessandro
    BLOOD, 2009, 114 (15) : 3216 - 3226
  • [45] Long-Term Immune Reconstitution in ADA-Deficient Patients Treated With Elapegademase: A Real-World Experience
    Murguia-Favela, Luis
    Suresh, Sneha
    Wright, Nicola A. M.
    Alvi, Saima
    Tehseen, Sarah
    Hernandez-Trujillo, Vivian
    Seroogy, Christine M.
    Haddad, Elie
    Nieves, Daime
    Hershfield, Michael S.
    Walter, Jolan E.
    Pettiford, Leah
    Kamani, Naynesh R.
    Keller, Michael D.
    Pham-Huy, Anne
    Grunebaum, Eyal
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (06): : 1725 - 1733
  • [46] Clinical Significance of Inherited Chromosomally Integrated HHV-6 (iciHHV-6) in the Setting of ADA-Deficient SCID
    Purswani, Pooja
    Hall, Geoffrey
    Mousallem, Talal
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S37 - S37
  • [47] MURINE LYMPHOCYTES AND LYMPHOCYTE LINES SECRETE ADENOSINE-DEAMINASE (ADA)
    STRAUSS, PR
    PEDIATRIC RESEARCH, 1985, 19 (07) : 778 - 778
  • [48] EFFECT OF SOME ANTIBIOTICS ON MITOGENESIS OF HUMAN-LYMPHOCYTES
    RACHKOV, SM
    BEKBERGENOV, BM
    KOROLEV, PN
    GLESER, GA
    ANTIBIOTIKI, 1981, 26 (01): : 55 - 58
  • [49] DEOXYADENOSINE TOXICITY ON ADENOSINE-DEAMINASE DEFICIENT LYMPHOCYTES
    UBERTI, J
    LIGHTBODY, JJ
    JOHNSON, RM
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 1223 - 1223
  • [50] IMMUNOPHARMACOLOGIC STUDIES OF ADENOSINE-DEAMINASE DEFICIENT LYMPHOCYTES
    POLMAR, SH
    WETZLER, EM
    STERN, RC
    PEDIATRIC RESEARCH, 1977, 11 (04) : 492 - 492
12345